{"id":386678,"date":"2017-11-22T00:00:00","date_gmt":"2017-11-22T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360oe0028-medtech-orthopedic-extremity-devices-europe-2018-market-analysis\/"},"modified":"2026-04-14T10:07:09","modified_gmt":"2026-04-14T10:07:09","slug":"m360oe0028-medtech-orthopedic-extremity-devices-europe-2018-market-analysis","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360oe0028-medtech-orthopedic-extremity-devices-europe-2018-market-analysis\/","title":{"rendered":"Orthopedic Extremity Devices | Europe | 2018 | Market Analysis"},"content":{"rendered":"<p>The European orthopedic extremity device market will\u00a0grow at a\u00a0moderate\u00a0pace\u00a0through 2026, primarily as a result of favorable demographics, innovation in underpenetrated segments, an ongoing focus on surgeon training, and the uptake of premium-priced products. However, lingering economic uncertainty, cost constraints on hospitals, and the prevalence of alternative techniques will limit\u00a0<abbr title=\"Average Selling Price\">ASP<\/abbr>s and revenue expansion over the forecast period.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic extremity devices\u00a0in Europe\u00a0across a 10-year period.<\/p>\n<p>\u00a0<\/p>\n<p><strong>Despite cost-containment efforts throughout Europe, some device segments will continue to drive revenue growth\u00a0in the European orthopedic extremity device market.<\/strong><\/p>\n<p>Which device segments are relatively underpenetrated?<\/p>\n<p>What are some of the innovative devices that have been launched in these segments?<\/p>\n<p>What strategies are companies employing to increase their market shares in these segments?<\/p>\n<p><strong>Some technologies being launched in the orthopedic extremity device market have steep learning curves.<\/strong><\/p>\n<p>What strategies are companies using to increase the penetration of these technologies?<\/p>\n<p>How can these technologies compete with established alternatives currently on the market?<\/p>\n<p><strong>The ris\u200bing influence of\u00a0<abbr title=\"Group Purchasing Organization\">GPO<\/abbr>s and continued austerity measures in the European market<\/strong><strong>\u00a0have placed downward pressure on the pricing of orthopedic extremity devices.<\/strong><\/p>\n<p>Which device segments will face the greatest pricing pressures?<\/p>\n<p>What should companies do to drive greater adoption of newer technologies in the face of such cost constraints?<\/p>\n","protected":false},"template":"","class_list":["post-386678","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-orthopedics","medtech-geography-europe","medtech-date-889"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386678\/revisions"}],"predecessor-version":[{"id":388177,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386678\/revisions\/388177"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}